跳至主要内容
临床试验/NCT01032967
NCT01032967已完成3 期

Multicenter Prospective Randomized Trial Comparing Standard Esophagectomy With Chemoradiotherapy for Treatment of Squamous Esophageal Cancer: Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)

Chinese University of Hong Kong0 个研究点目标入组 40 人开始时间: 2000年7月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
40
主要终点
Overall survival and disease-free survival

研究概览

简要总结

The aim of this study is to compare outcomes in patients with operable squamous carcinoma of the esophagus who have received either surgery or definitive chemoradiation (CRT).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible patients had mid or lower thoracic esophageal cancers that were confirmed on histology to be a squamous cell carcinoma deemed to be resectable.

排除标准

  • The investigators excluded those patients who had distant metastasis to solid visceral organs or local invasion into trachea, descending aorta, or recurrent laryngeal nerve.
  • Those patients who were older than 75 years or who had a serious premorbid condition or a poor physical status that compromised a thoracotomy were also excluded.

结局指标

主要结局

Overall survival and disease-free survival

时间窗: 2 year and 5 year

次要结局

  • Quality of life and function outcomes(2 year)

研究者

申办方类型
Other

相似试验

Surgery or Chemoradiation for Esophageal Cancer | 临床试验